Company Filing History:
Years Active: 2025
Title: Maria Hinterberger: Innovator in Cancer Therapy
Introduction
Maria Hinterberger is a prominent inventor based in Sauerlach, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on enhancing therapeutic methods to improve patient outcomes in oncology.
Latest Patents
Maria Hinterberger holds a patent for a groundbreaking therapy aimed at treating cancer. The patent, titled "Therapy for treating cancer with an intratumoral or intravenous administration of a recombinant MVA encoding 4-1BBL (CD137L) and/or CD40L," describes a composition and related methods for reducing tumor volume and increasing the survival of cancer patients. This composition includes a recombinant MVA encoding a Tumor Associated Antigen (TAA) along with 4-1BBL and/or CD40L, which can be administered through various methods, including intravenous and intratumoral routes. She has 1 patent to her name.
Career Highlights
Maria is currently associated with Bavarian Nordic A/S, a company known for its focus on innovative cancer therapies and vaccines. Her role at the company allows her to contribute to the development of advanced treatment options for patients suffering from cancer.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Henning Lauterbach and José Medina Echeverz. These collaborations have further enriched her research and development efforts in the field of cancer therapy.
Conclusion
Maria Hinterberger is a dedicated inventor whose work in cancer therapy is paving the way for new treatment methodologies. Her innovative approach and commitment to improving patient care are commendable.